Trabectedin for reversing platinum resistance and resensitization to platinum in patients with recurrent ovarian cancer. [electronic resource]
Producer: 20190401Description: 271-280 p. digitalISSN:- 1744-8301
- Aged
- Aged, 80 and over
- Clinical Trials as Topic
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Drug Resistance, Neoplasm -- drug effects
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Platinum -- administration & dosage
- Retrospective Studies
- Trabectedin -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.